Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1

por Awada, Gil, Serruys, Daphne, Schwarze, Julia Katharina, Van De Voorde, Lien, Duerinck, Johnny, Neyns, Bart
Publicado 2020